Search
SP1049C
go.drugbank.com/drugs/DB04978Experimental[A260416] It is designed to overcome drug resistance in a number of cancers. It has successfully completed Phase 1 trials. Phase 2 results are currently under final review. … SP1049C is a novel anthracycline chemotherapeutic agent containing [doxorubicin] and two nonionic pluronic block copolymers.
Categories: Compounds used in a research, industrial, or household settingSPP 301
go.drugbank.com/drugs/DB05290InvestigationalSPP301 (Avosentan) is a potent and highly selective ET[A] receptor blocker and is clinically investigated in diabetic nephropathy.
Banoxantrone
go.drugbank.com/drugs/DB04975InvestigationalBanoxantrone is a highly selective bioreductive drug that is activated in, and is preferentially toxic to, hypoxic cells in tumours. … It has been shown to work synergistically with fractionated radiation to significantly delay growth of tumours compared to administration of either banoxantrone or radiation alone.
Concanamycin A
go.drugbank.com/drugs/DB14062ExperimentalConcanamycin A is an H+-ATPase (vacuolar) inhibitor.
Synonyms: Concanamycin ASulfamoxole
go.drugbank.com/drugs/DB08798ExperimentalSulfamoxole is an antibacterial in the sulfonamide class.
Ospemifene
go.drugbank.com/drugs/DB04938ApprovedOspemifene is a new selective non-hormonal estrogen receptor modulator (SERM) that is used for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause
Phenothiazine
go.drugbank.com/drugs/DB11447ExperimentalVet approvedPhenothiazine (PTZ) is an organic thiazine compound.
Aluminium acetoacetate
go.drugbank.com/drugs/DB13280ExperimentalAluminium acetoacetate is an aluminum containing antacid.
Rimazolium
go.drugbank.com/drugs/DB13289ExperimentalRimazolium is an experimental analgesic drug [A176186].
Diphenyleneiodonium
go.drugbank.com/drugs/DB17025ExperimentalAn NADPH oxidase 2 (NOX2) inhibitor.[A252987]